Table 1.
Variable
|
ALPPS, n = 37
|
Age, yr | 45 (26-75) |
Sex, women/man, n (%) | 3 (8.1)/34 (91.9) |
BMI, kg/m2 | 22.2 (17.99-30.09) |
AFP, ≥ 400 ng/mL/< 400 ng/mL, n (%) | 19 (51.4)/18 (48.6) |
Degree of liver fibrosis, n | |
No fibrosis | 7 |
Mild fibrosis | 2 |
Moderate fibrosis/fibrosis | 8 |
Cirrhosis, n (%) | 20 (54.1) |
MELD score | 5.12 (0.75-11.00) |
ICGR15, % | 5.3 (1.3-18.8) |
Child-Pugh class, A/B/C, n | 36/1/0 |
BCLC staging, A/B/C, n | 10/7/20 |
AFP: Alpha-fetoprotein; ALPPS: Association liver partition and portal vein ligation for staged hepatectomy; BCLC: Barcelona Clinic Liver Cancer; BMI: Body mass index; ICGR15: Indocyanine green retention rate at 15 min; MELD: Model for end-stage liver disease.